Herbert Johannes Pfister

Herbert Johannes Pfister's AcademicInfluence.com Rankings

Philosophy

#8049

World Rank

#11355

Historical Rank

Logic

#5081

World Rank

#6443

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Herbert Johannes Pfister's Degrees

PhD Biomedical Sciences University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Herbert Johannes Pfister Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Herbert Johannes Pfister's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer (2007) (446)
Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. (2003) (421)
Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas (2001) (360)
Chapter 8: Human papillomavirus and skin cancer. (2003) (336)
Biology and biochemistry of papillomaviruses. (1984) (300)
Human papilloma viruses (HPV): characterization of four different isolates. (1977) (264)
Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts (2004) (248)
Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. (2005) (208)
Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. (2005) (205)
Anal carcinoma in human immunodeficiency virus‐positive men: results of a prospective study from Germany (2010) (172)
Characterization of human papillomavirus type 13 from focal epithelial hyperplasia Heck lesions (1983) (168)
The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. (1994) (167)
Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri (1988) (156)
Beta genus papillomaviruses and skin cancer. (2015) (153)
Prevalence of deletions of YY1‐binding sites in episomal HPV 16 DNA from cervical cancers (1994) (147)
Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. (2000) (146)
Merkel Cell Polyomavirus DNA in Persons without Merkel Cell Carcinoma (2009) (146)
Human papillomavirus and skin cancer (2003) (142)
Human papillomaviruses and genital cancer. (1987) (137)
Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. (2006) (134)
Role of HPV in cutaneous premalignant and malignant tumors. (1997) (133)
Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. (2003) (132)
Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. (2010) (128)
Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. (2005) (127)
A Case–Control Study of Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients (2011) (119)
Primary HIV Drug Resistance and Efficacy of First-Line Antiretroviral Therapy Guided by Resistance Testing (2006) (119)
Correlation between human papillomavirus (HPV) type and histology of warts. (1982) (117)
High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population (2003) (112)
Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis (1986) (112)
Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. (2009) (107)
Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. (2008) (105)
Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. (2009) (103)
Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? (2003) (101)
Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7 (2000) (101)
Human papillomavirus 16 dna in cervical cancers and in lymph nodes of cervical cancer patients: A diagnostic marker for early metastases? (1989) (99)
Detection of Adenoviruses and Rotaviruses in Drinking Water Sources Used In Rural Areas of Benin, West Africa (2009) (98)
The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. (2005) (98)
Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. (1999) (96)
Human papilloma virus 5-DNA in a carcinoma of an epidermodysplasia verruciformis patient infected with various human papillomavirus types. (1983) (95)
Human papillomaviruses and skin cancer. (1992) (94)
Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. (1999) (93)
Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. (2005) (90)
The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. (2008) (90)
Human Papillomavirus Load in Eyebrow Hair Follicles and Risk of Cutaneous Squamous Cell Carcinoma (2013) (89)
Papillomavirus DNA in Basal Cell Carcinomas of Immunocompetent Patients: an Accidental Association? (2000) (87)
Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication (1988) (86)
Oncogenic Human Papillomavirus DNA Loads in Human Immunodeficiency Virus-Positive Women with High-Grade Cervical Lesions Are Strongly Elevated (2003) (86)
The Papillomavirus E2 Protein Binds to and Synergizes with C/EBP Factors Involved in Keratinocyte Differentiation (2003) (85)
Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from upper‐volta (1981) (85)
Seroepidemiological studies of human papilloma virus (HPV‐1) infections (1978) (85)
Evolution of raltegravir resistance during therapy. (2009) (84)
Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. (2007) (83)
Compensatory Mutations at the HIV Cleavage Sites P7/P1 and P1/P6-Gag in Therapy-Naive and Therapy-Experienced Patients (2006) (83)
Use of Interferon-Alpha in Recurrent Respiratory Papillomatosis: 20-Year Follow-up (2005) (83)
High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. (2009) (81)
Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. (2008) (76)
Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference (2001) (76)
Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment. (1988) (76)
Intrafamilial Transmission and Family-Specific Spectra of Cutaneous Betapapillomaviruses (2008) (75)
Human Papillomavirus Type 8 Interferes with a Novel C/EBPβ-Mediated Mechanism of Keratinocyte CCL20 Chemokine Expression and Langerhans Cell Migration (2012) (75)
CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma. (1999) (74)
Partial characterization of a new type of bovine papilloma viruses. (1979) (70)
The presence of antibodies against virus‐like particles of epidermodysplasia verruciformis‐associated humanpapillomavirus type 8 in patients with actinic keratoses (2000) (69)
High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. (1999) (69)
Human papillomavirus and immunosuppression. (2014) (66)
Prevalence of antibodies to human papillomavirus type 8 in human sera (1990) (65)
Human papillomavirus mediated inhibition of DNA damage sensing and repair drives skin carcinogenesis (2015) (62)
Prevalence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. (1998) (60)
Expression of Betapapillomavirus Oncogenes Increases the Number of Keratinocytes with Stem Cell-Like Properties (2013) (59)
Relationship of papillomaviruses to anogenital cancer. (1987) (59)
Inter‐laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection (1989) (59)
Merkel cell polyomavirus infection in HIV-positive men. (2011) (58)
Case–control study of genus‐beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma (2014) (58)
Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. (2005) (58)
Trends of prevalence of primary HIV drug resistance in Germany. (2007) (57)
A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome. (2008) (57)
Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study (2017) (56)
Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis. (2013) (56)
Molecular cloning and characterization of the DNAs of human papillomaviruses 19, 20, and 25 from a patient with epidermodysplasia verruciformis (1984) (55)
HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes (2007) (55)
UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes (2004) (55)
Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients (2012) (54)
Quantification of beta-human papillomavirus DNA by real-time PCR (2010) (54)
Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. (1995) (53)
Monochloroacetic acid and 60% salicylic acid as a treatment for simple plantar warts: effectiveness and mode of action (1988) (53)
The predominant mRNA class in HPV16‐infected genital neoplasias does not encode the e6 or the E7 protein (1993) (52)
Prevalence of minor variants of HIV strains at reverse transcriptase position 103 in therapy-naïve patients and their impact on the virological failure. (2009) (52)
Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer (2011) (52)
Diversity of human papillomavirus types in periungual squamous cell carcinoma (2009) (51)
Human papillomavirus infection in Netherton’s syndrome (2001) (51)
Effect of oral aromatic retinoid (Ro 10-9359) on human papilloma virus-2-induced common warts. (1983) (51)
Papillomaviruses: Particles, Genome Organisation and Proteins (1987) (50)
Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models. (2012) (49)
A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2. (2002) (48)
Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: detection of a new sequence related to epidermodysplasia verruciformis associated types. (1997) (48)
Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated polyomavirus in HIV-infected men. (2014) (48)
Anatomy, taxonomy and evolution of papillomaviruses. (1994) (48)
Loss of IL-6 Receptor Expression in Cervical Carcinoma Cells Inhibits Autocrine IL-6 Stimulation: Abrogation of Constitutive Monocyte Chemoattractant Protein-1 Production1 (2000) (47)
Cutaneous human papillomaviruses down-regulate AKT1, whereas AKT2 up-regulation and activation associates with tumors. (2007) (46)
Late promoter of human papillomavirus type 8 and its regulation (1992) (46)
The Human Papillomavirus Type 8 E2 Protein Suppresses β4-Integrin Expression in Primary Human Keratinocytes (2004) (45)
Characterization of human papillomavirus 3 in warts of a renal allograft patient. (1979) (45)
E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors (1996) (45)
Papillomaviruses: General Description, Taxonomy, and Classification (1987) (45)
Smoking and anal high-risk human papillomavirus DNA loads in HIV-positive men who have sex with men. (2015) (44)
Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women. (2000) (44)
Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses (2003) (43)
Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men. (2012) (43)
Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UV-A. (2004) (43)
Interaction of Human Papillomavirus 8 Regulatory Proteins E2, E6 and E7 with Components of the TFIID Complex (1998) (40)
Papovaviridae: The Papillomaviruses (1988) (40)
Expression of matrix metalloproteinase (MMP)‐2, MMP‐9, MMP‐13, and MT1‐MMP in skin tumors of human papillomavirus type 8 transgenic mice (2006) (39)
CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-kappaB and STAT3 activation. (2001) (39)
The role of human papillomavirus in anogenital cancer. (1996) (38)
Detection of new human papillomavirus sequences in skin lesions of a renal transplant recipient and characterization of one complete genome related to epidermodysplasia verruciformis-associated types. (1998) (38)
In vitro expressed HPV 8 E 6 protein does not bind p 53 (2005) (38)
Transcription of papillomavirus genomes. (1994) (38)
Human papillomavirus‐associated induction of human β‐defensins in anal intraepithelial neoplasia (2009) (37)
Detection and characterization of enteroviruses and parechoviruses in healthy people living in the South of Côte d'Ivoire. (2015) (36)
Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16. (1999) (36)
Sensitive Detection of Viral Transcripts in Human Tumor Transcriptomes (2013) (35)
Communication: papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association?TITLE. (2000) (35)
Anti-contamination primers to improve specificity of polymerase chain reaction in human papillomavirus screening (1990) (35)
High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates (2010) (35)
Papillomavirus DNA in warts of immunosuppressed renal allograft recipients (2004) (34)
Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets. (2011) (34)
ONCOGENIC VIRUSES (1961) (33)
Partial characterization of the proteins of human papilloma viruses (HPV) 1-3. (1977) (32)
Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter (1994) (32)
Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation. (2007) (31)
p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus‐infected men and correlates with the decline of lesional high‐risk human papillomavirus DNA load (2007) (31)
Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genome region (1990) (30)
Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients (2011) (30)
Acanthosis nigricans maligna. Clinical and virological investigations. (1984) (30)
Epidemiology of Transmitted Drug Resistance in Chronically HIV-Infected Patients in Germany: The RESINA Study 2001–2009 (2012) (29)
Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia. (2009) (29)
Classification of the papillomaviruses--mapping the genome. (1986) (29)
Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of epidermodysplasia verruciformis-associated human papillomavirus type 8. (2003) (28)
Expression of proliferative biomarkers in anal intraepithelial neoplasia of HIV-positive men. (2010) (27)
Point mutations in SP1 motifs in the upstream regulatory region of human papillomavirus type 18 isolates from cervical cancers increase promoter activity. (1998) (27)
High-grade Dysplasia in Anogenital Warts of HIV-Positive Men. (2016) (27)
Prevalence of C-terminal gag cleavage site mutations in HIV from therapy-naïve patients. (2009) (26)
The E7 protein of human papillomavirus 8 is a nonphosphorylated protein of 17 kDa and can be generated by two different mechanisms. (1990) (26)
Duplication of enhancer sequences in human papillomavirus 6 from condylomas of the mamilla. (1989) (26)
HPV 1 DNA in lesions of focal epithelial hyperplasia Heck (2004) (26)
Novel human papillomavirus (HPV) DNA sequences from recurrent cutaneous and mucosal lesions of a stoma-carrier. (1998) (26)
Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice. (2010) (25)
Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. (1997) (25)
Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy. (2005) (25)
Human papillomavirus 5 and 8 E6 downregulate interleukin-8 secretion in primary human keratinocytes. (2010) (25)
Extrachromosomal bovine papillomavirus type 1 DNA in hamster fibromas and fibrosarcomas. (1981) (25)
Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical scrapes (1999) (25)
Genetic relationship among human papillomaviruses associated with benign and malignant tumours of patients with epidermodysplasia verruciformis. (1987) (25)
HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion (2017) (24)
5% imiquimod suppositories decrease the DNA load of intra-anal HPV types 6 and 11 in HIV-infected men after surgical ablation of condylomata acuminata. (2006) (24)
Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls. (2010) (23)
Human Papillomavirus Type 8 E2 Protein Unravels JunB/Fra-1 as an Activator of the β4-Integrin Gene in Human Keratinocytes (2009) (23)
Papilloma virus-induced tumors contain a virus-specific transcript. (1982) (23)
E7 proteins from high- and low-risk human papillomaviruses bind to TGF-β-regulated Smad proteins and inhibit their transcriptional activity (2006) (22)
The E2 protein of human papillomavirus type 8 increases the expression of matrix metalloproteinase-9 in human keratinocytes and organotypic skin cultures (2011) (22)
Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy (2015) (22)
Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes (2005) (22)
Regulatory interactions of transcription factor YY1 with control sequences of the E6 promoter of human papillomavirus type 8. (1997) (22)
Partial characterization of a canine oral papillomavirus. (1980) (21)
The levels of epithelial anchor proteins β-catenin and zona occludens-1 are altered by E7 of human papillomaviruses 5 and 8. (2016) (21)
Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination (2014) (21)
Children and partners of patients with recurrent respiratory papillomatosis have no evidence of the disease during long-term observation. (2006) (20)
Mutational patterns in the frameshift-regulating site of HIV-1 selected by protease inhibitors (2012) (20)
Human papillomavirus 25-related DNA in solitary keratoacanthoma (2004) (20)
Recurrent vulvar Buschke-Löwenstein's tumor-like condylomata acuminata and Hodgkin's disease effectively treated with recombinant interferon-alpha 2c gel as adjuvant to electrosurgery. (1989) (19)
Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach. (2011) (18)
Constitutive transcriptional activator of Epidermodysplasia verruciformis-associated human papillomavirus 8. (1993) (18)
Human Papillomavirus Type 8 E6 Oncoprotein Inhibits Transcription of the PDZ Protein Syntenin-2 (2012) (18)
Cell differentiation-related gene expression of human papillomavirus 33 (2004) (18)
Prevalence and multiplicity of cutaneous beta papilloma viruses in plucked hairs depend on cellular DNA input. (2009) (18)
Genome organization of herpesvirus aotus type 2 (1985) (17)
Upregulation of lipocalin-2 in human papillomavirus-positive keratinocytes and cutaneous squamous cell carcinomas. (2011) (17)
Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen‐presenting cells in skin (2017) (16)
Human papillomavirus type 26-associated periungual squamous cell carcinoma in situ in a HIV-infected patient with concomitant penile and anal intraepithelial neoplasia. (2005) (16)
Human papillomaviruses and impaired immunity vs epidermodysplasia verruciformis. (1987) (15)
Molecular diagnosis of persistent human papilloma virus infections. (1996) (15)
Cloning and characterization of papillomavirus type 2c DNA. (1984) (15)
Soluble interleukin-6 receptor activates the human papillomavirus type 18 long control region in SW756 cervical carcinoma cells in a STAT3-dependent manner. (2001) (15)
Two independently transforming functions of human papillomavirus 8. (1989) (14)
Seroepidemiologic studies of bovine papillomavirus infections. (1979) (14)
Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor (1994) (14)
Enhanced StefinA and Sprr2 expression during papilloma formation in HPV8 transgenic mice. (2011) (14)
Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1 (1997) (14)
HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, Germany (2011) (14)
Genome Sequence of Novel Human Parechovirus Type 17 (2017) (14)
Human papillomavirus type 8 contains cis-active positive and negative transcriptional control sequences. (1990) (14)
High prevalence of human papillomaviruses in Ghanaian pregnant women (2016) (13)
Distribution and density of CD1a+ and CD83+ dendritic cells in HPV-associated laryngeal papillomas. (2009) (13)
The CD3-Zeta Chimeric Antigen Receptor Overcomes TCR Hypo-Responsiveness of Human Terminal Late-Stage T Cells (2012) (13)
No evidence for a role of xenotropic murine leukaemia virus-related virus and BK virus in prostate cancer of German patients (2012) (13)
Papillomaviruses and Human Cancer (1990) (13)
[Condyloma acuminata and other HPV-associated diseases of the genitals, anus and urethra]. (2007) (12)
No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. (2010) (12)
Application of Luminex Gastrointestinal Pathogen Panel to human stool samples from Côte d'Ivoire. (2015) (12)
Human papillomavirus DNA in conjunctival papilloma (2005) (12)
High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates (2013) (12)
Chronic sun exposure and age are inversely associated with nevi in adult renal transplant recipients. (1996) (12)
Demonstration of human papillomavirus DNA in two keratoacanthomas (2004) (12)
Characterization of proteins of human papilloma viruses (HPV) and antibody response to HPV 1 (1978) (12)
Demonstration of human papilloma virus type 2 DNA in Bowen's disease (2004) (12)
Deletion of epidermal Rac1 inhibits HPV-8 induced skin papilloma formation and facilitates HPV-8- and UV-light induced skin carcinogenesis (2016) (12)
Distinct functions of epidermal and myeloid-derived VEGF-A in skin tumorigenesis mediated by HPV8. (2015) (11)
Longitudinal study of seroprevalence and serostability of 34 human papillomavirus types in European organ transplant recipients. (2013) (11)
Human papillomavirus DNA in genital cancers, metastases, and lymph nodes. (1995) (11)
The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431V (2010) (11)
Attachment of a Long-Tailed Rhizobium Bacteriophage to the Pili of Its Host (1975) (11)
Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates. (2010) (10)
Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity. (2016) (10)
[Condylomata acuminata in children--detection of HPV 6/11 and 2. Local therapy with interferon-beta hydrogel]. (1992) (10)
2′,5′-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis (2004) (10)
Parameters Influencing Baseline HIV-1 Genotypic Tropism Testing Related to Clinical Outcome in Patients on Maraviroc (2015) (10)
Factors associated with the seroprevalence of 26 cutaneous and two genital human papillomavirus types in organ transplant patients. (2012) (10)
Unique topography of DNA-protein interactions in the non-coding region of epidermodysplasia verruciformis-associated human papillomaviruses. (1991) (9)
Induction of Tyrosine Phosphorylation of UV-Activated EGFR by the Beta-Human Papillomavirus Type 8 E6 Leads to Papillomatosis (2017) (9)
Tumor prevention in HPV8 transgenic mice by HPV8-E6 DNA vaccination (2014) (9)
German evidence and consensus‐based (S3) guideline: Vaccination recommendations for the prevention of HPV‐associated lesions (2021) (8)
Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation (2017) (8)
Extensive human papillomavirus type 7-associated orofacial warts in an immunocompetent patient. (2001) (8)
Prospects for Vaccination (1990) (8)
Heterogeneity of human papilloma viruses. (1978) (8)
[HPV-associated tonsillar cancer. An update]. (2004) (8)
Relation of papillomaviruses to anogenital cancer. (1991) (8)
Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics (2015) (8)
[HPV and skin neoplasia]. (2008) (7)
Increased human papillomavirus type 31 DNA load in a verrucous high‐grade intraepithelial neoplasia of a human immunodeficiency virus‐infected patient with extensive bowenoid papulosis (2007) (7)
Genital Papillomavirus Infections (1990) (7)
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]. (2007) (7)
Natural History of Cutaneous Human Polyomavirus Infection in Healthy Individuals (2021) (7)
[Postoperative interferon hydrogel treatment. A method for the successful therapy of chronic persistent giant condylomas in an immunologically deficient patient with Hodgkin's disease]. (1988) (7)
An analysis of clustering of betapapillomavirus antibodies. (2010) (6)
Molecular Biology of Genital HPV Infections (1990) (6)
Chromosomal changes in bovine papillomavirus type 1-induced Syrian hamster tumors. (1984) (6)
Anal chromoendoscopy using gastroenterological video-endoscopes: A new method to perform high resolution anoscopy for diagnosing intraepithelial neoplasia and anal carcinoma in HIV-infected patients (2016) (6)
Human papillomavirus 8-L1 immune serum: a new diagnostic possibility for Epidermodysplasia verruciformis-specific HPVs. (1988) (6)
Specific rearrangements of human papillomavirus DNA provide molecular evidence for genetic heterogeneity of primary cervical cancers, recurrencies, and lymph node metastases in two patients. (1993) (6)
Papilloma virus particles in a fibroma of the tongue. (1980) (6)
A study of HPV 1, 2 and 4 antibody prevalence in patients presenting for treatment with cutaneous warts to general practitioners in N. Ireland (1988) (6)
Interaction of Papillomaviral Oncoproteins with Cellular Factors (2002) (6)
Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018. (2014) (5)
[Virus-induced papilloma of the conjunctiva. Detection of HPV 6a DNA]. (1990) (5)
Relevance of HIV Gag Cleavage Site Mutations in Failures of Protease Inhibitor Therapies (2008) (5)
[Heck's focal epithelial hyperplasia]. (1982) (5)
Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G source. (2010) (4)
Interferon regulatory factor 5.2 acts as a transcription repressor of Epidermodysplasia verruciformis-associated human papillomaviruses (2006) (4)
[Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline]. (2010) (4)
Circulating soluble tumour necrosis factor receptors in patients with epidermodysplasia verruciformis as compared to patients with cutaneous tumours in the general population. (2005) (4)
Prevalence of antibodies to HPV16-E7-protein does not differ between AIDS-patients with and without Kaposi's sarcoma. (1994) (4)
[Condylomata acuminata and other HPV associated disease pictures of the genitals, anus and urethra]. (2008) (4)
Human papillomavirus in nonmelanoma skin cancer? The phylogenetic tree of the papillomavirus family is not yet complete. (1996) (3)
Overlapping YY 1-and aberrant SP 1-binding sites proximal to the early promoter of human papillomavirus type 16 (1999) (3)
Humane Papillomviren (HPV) (2009) (3)
Vaccination against HPV-Associated Neoplasias (2014) (3)
[Presence of genetic rearrangements in E1/E2 regions of episomal HPV 16 isolates from cervical carcinomas 5-8]. (2000) (3)
Natural cell-mediated cytotoxicity of peripheral blood lymphocytes against target cells transfected with epidermodysplasia verruciformis-specific human papillomavirus type 8 L1 DNA sequences. (2004) (2)
Rapid onset of multifocal human papillomavirus 72‐associated oral intraepithelial neoplasia in a human immunodeficiency virus‐infected patient (2007) (2)
The adenoviral E1A oncoprotein activates the Smad7 promoter: requirement of a functional E-box. (2009) (2)
TUMOR VIRUSES – HUMAN (2008) (2)
Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models. (2014) (2)
Lack of integrin β5 in Merkel cell carcinomas and derived cell lines is frequently associated with Merkel cell polyomavirus positivity. (2012) (2)
Seasonal Influenza Virus Species in Patient Swab Samples Analyzed for the Presence of the Pandemic (H1N1) 2009 Influenza Virus (2009) (2)
[YY1 and its repressive effect on human papillomavirus 16 early promoter P97 existed widely among human epithelial cell lines]. (1998) (2)
Poly(I:C) treatment prevents skin tumor formation in the preclinical HPV8 transgenic mouse model. (2022) (1)
Erratum to "Detection and characterization of enteroviruses and parechoviruses in healthy people living in the South of Côte d'Ivoire" [J. Clin. Virol. 71 (2015) 40-43]. (2015) (1)
Editorial: Human Papillomaviruses and Polyomaviruses in Skin Cancer (2018) (1)
Prophylaxis and Early Detection of HPV-Related Neoplasia (2012) (1)
Free Communications (2017) (1)
High prevalence of bevirimat resistance mutations in non-B subtypes and in PI-resistant HIV isolates (2009) (1)
[Vaccination against HPV-associated neoplasias]. (2014) (1)
[Eruptive viral warts of the burn area]. (1990) (1)
Papilloma virus and squamous cell carcinoma in man. (1978) (1)
Cutaneous human papillomavirus early genes downregulate serine phosphorylated Akt1 while upregulating Akt2 expression (2007) (1)
Detection of a novel 1905C-->T mutation within the dihydropyrimidine dehydrogenase gene and potential for misclassification with the exon 14-skipping mutation. (2003) (1)
[The role of Papillomaviruses in the development of cancer of the skin]. (1990) (1)
High prevalence of human papillomaviruses in Ghanaian pregnant women (2016) (1)
Short Communication Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated polyomavirus in HIV-infected men (2014) (1)
Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohort (2013) (1)
[Removal of YY1 binding sites in HPV 16 LCR increases viral transforming activities on mouse fibroblasts]. (1999) (1)
Treatment of bovine-papillomavirus-type-1 (BPV)-transformed mouse cells with aromatic retinoid and retinoic acid (2004) (1)
The levels of epithelial anchor proteins β-catenin and ZO-1 are altered by E7 of HPV5 and HPV8. (2015) (1)
HPV Infection in Mothers of Children with Recurrent Respiratory Papillomatosis (2008) (0)
Interactions of the cellular regulatory protein YY1 with transcription control sequences of the human papillomavirus 8 (HPV8) (2007) (0)
[No switch region is found in the regulatory sequence of HPV 16 for promoter P97]. (1999) (0)
Genome organization and complete nucleotide sequence of human papillomavirus type 13 (1991) (0)
P.015 Prevalence and risk factors of betapapillomavirus infections in immunocompetent individuals without skin cancer (2009) (0)
Geno2pheno and the Arevir database: tools for determination of clinically relevant cut-offs and prediction of viral load change from HIV-1 genotype. (2003) (0)
Molecular Biology of Papilloma Virus (1987) (0)
Organotypic Cultures of Skin Causes Invasion of Human Keratinocytes into the Dermis in The E 7 Protein of Cutaneous Human Papillomavirus Type 8 (2005) (0)
Tumor prevention in HPV8 transgenic mice by HPV8-E6 DNA vaccination (2014) (0)
Association between betapapillomavirus seropositivity and keratinocyte carcinoma-prospects for prophylactic vaccination? (2015) (0)
Author index (2005) (0)
KAPITEL C7 – Papillome (2008) (0)
Epidermodyplasia verruciformis human papillomavirus types in skin samples of a psoriasis patient with widespread cutaneous carcinomas (1998) (0)
The Human Papillomavirus Type 8 E2 Protein Induces Skin Tumors in Transgenic Mice. Commentary (2008) (0)
Efficacy of first-line antiretroviral therapy: differences between hospital-based outpatient units and private practices in Germany (2012) (0)
Virology and Pathogenesis (2012) (0)
Erratum to: Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients (2010) (0)
Human Papillomaviruses are closely related to nonhuman primate papillomaviruses (1991) (0)
HPV-DNA-Integration in Oropharynxkarzinomen (2004) (0)
Human Papilloma Virus 5-DNA in a Carcinoma of an Epidermodysplasia Verruciformis Patient Infected with Various Human Papillomavirus Types 1 (2006) (0)
Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients (2011) (0)
Human papillomavirus mediated inhibition of DNA damage sensing and repair drives skin carcinogenesis (2015) (0)
The Invasive Species Forecasting System: A Space-Based Decision Support Infrastructure for Managing Biological Invasions (2004) (0)
Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer (2011) (0)
Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics (2015) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
KLK6-mediated down-regulation of Keratin10 is commonly employed by skin-tropic viruses to propagate in skin and is required for blister formation in VZV infection (2016) (0)
How do human papillomavirus and varicella zoster virus disrupt epidermal structure? The pivotal role of kallikrein 6 (2015) (0)
Mutational patterns in the frameshift-regulating site of HIV-1 selected by protease inhibitors (2011) (0)
Detection of Epidermodysplasia verruciformis (EV) - DNA sequences in plane warts of immunocompetent patients not associated with malignancy - a family study (1998) (0)
Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy (2015) (0)
Human Papilloma Virus 5-DNA in a Carcinoma of an Epidermodysplasia Verruciformis Patient Infected with Various Human Papillomavirus Types1 (2006) (0)
Increased prevalence of epidermodysplasia verruciformis-type HPV DNA sequences in hairs, and increased HPV 8 antibody levels in the serum of PUVA-treated patients with psoriasis (1999) (0)
New Human Papillomavirus (HPV)-DNA sequences from cutaneous, mucocutaneous and intestinal lesions of an immunocompetent stoma-carrier (1997) (0)
[Comment. HPV7-induced skin warts in butchers: an occupational disease?]. (2003) (0)
Disruption of epidermal specific Stat3 expression and delayed skin tumor development in HPV8 transgenic mice (2009) (0)
Involvement ofHumanPapillomavirus Type8GenesE6andE7in Transformation andReplication (1988) (0)
Skin changes in successfully treated Hodgkin's disease patient (1997) (0)
Modifications of keratinocyte functions by human papillomaviruses (2005) (0)
HPV-Infection in HIV-Positive Men Who Have Sex with Men (MSM) (2011) (0)
Production Monocyte Chemoattractant Protein-1 Stimulation : Abrogation of Constitutive Carcinoma Cells Inhibits Autocrine IL-6 Loss of IL-6 Receptor Expression in Cervical (2000) (0)
Upregulation of membrane type-1 metalloproteinase by the HPV E7 oncoprotein in human keratinocytes (1998) (0)
Papillomaviruses inform us that humans are closely related to monkeys (1991) (0)
No evidence for a role of xenotropic murine leukaemia virus-related virus and BK virus in prostate cancer of German patients (2011) (0)
Prevalence ofAntibodies toHuman Papillomavirus Type8 inHumanSera (1990) (0)
Transcriptional Silencer oftheHumanPapillomavirus Type8 LatePromoter Interacts Alternatively withtheViral trans Activator E2orwithaCellular Factor (1994) (0)
Optimisation of baseline genotypic testing for safe and efficient maraviroc administration (2012) (0)
Comprar Prophylaxis And Early Detection Of Hpv-Related Neoplasia | H. Pfister | 9783805599641 | Karger AG (2012) (0)
Epstein-Barr Virus and Human Cancer, Toyoro Osato, Kenzo Takada, Masayoshi Tokunaga, in: Monograph on Cancer Research No. 45, Japanese Cancer Ass., VII. S. Karger-Verlag, Basel (1998), 190 pages, 53 figures, 25 tables, hard cover, sFr 280.-, DM 335.-, US$ 243.50. (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Herbert Johannes Pfister?

Herbert Johannes Pfister is affiliated with the following schools: